首页 > 最新文献

Gastroenterology and Hepatology From Bed to Bench最新文献

英文 中文
The prevalence of latent/chronic infection in liver transplant candidates in Taleghani Hospital of Tehran, Iran, from 2020 until 2021. 2020年至2021年,伊朗德黑兰Taleghani医院肝移植候选者中潜伏/慢性感染的患病率
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.22037/ghfbb.v16i1.2664
Amirhassan Rabbani, Hesameddin Eghlimi, Mina Khoshkbarforoushan, Mana Baziboroun

Aim: The present study aimed to study the prevalence of various latent infections in pre-transplanted patients.

Background: Due to chronic immunosuppressive therapy, patients receiving organ transplants are at risk for reactivation of various infections. Due to the complications in the course of diagnosing and treating the post-transplant infection, screening transplant recipients and donors is vital.

Methods: This retrospective cohort study was performed between March 2020 and 2021. A total of 193 patients receiving a liver transplant in Taleghani Hospital, Tehran, Iran were enrolled.

Results: One-hundred and three (53.4%) patients were men, with an average age of 48.4 ± 13.3 years. Among viruses, 177 (91.7%) patients had a positive IgG titer for CMV. Anti-EBV IgG was positive in 169 (87.6%) patients. One-hundred and seventy-five (90.7%) patients had a positive IgG titer for the VZV. One-hundred and sixty-six (86.0%) cases had positive IgG anti-HSV antibodies. According to our findings, none of the patients were infected with HIV, but 9 (4.7%) cases and 141 (73.1%) had positive anti-HCV and anti-HAV IgG antibodies, respectively. HBV surface (HBs) antigen was also reported positive in 17 (8.8%) patients, while the HBs antibody was positive in 29 (15.0%) patients.

Conclusion: In our study, most of the patients had positive serology for latent viral infections such as CMV, EBV, VZV, and HSV, but the prevalence of latent tuberculosis and viral hepatitis was low among transplant candidates.

目的:本研究旨在了解移植前患者各种潜伏感染的流行情况。背景:由于慢性免疫抑制治疗,接受器官移植的患者有各种感染再激活的危险。由于移植后感染在诊断和治疗过程中的并发症,筛选移植受体和供体是至关重要的。方法:该回顾性队列研究于2020年3月至2021年3月进行。共有193名患者在伊朗德黑兰的Taleghani医院接受肝脏移植。结果:男性103例(53.4%),平均年龄48.4±13.3岁。病毒中有177例(91.7%)CMV IgG滴度阳性。抗ebv IgG阳性169例(87.6%)。175例(90.7%)患者VZV IgG抗体阳性。抗hsv抗体IgG阳性166例(86.0%)。结果显示,所有患者均未感染HIV,但抗hcv抗体阳性9例(4.7%),抗hav抗体阳性141例(73.1%)。HBV表面抗原(HBs)阳性17例(8.8%),HBs抗体阳性29例(15.0%)。结论:在我们的研究中,大多数患者的CMV、EBV、VZV和HSV等潜伏病毒感染的血清学阳性,但在移植候选人中潜伏结核和病毒性肝炎的患病率较低。
{"title":"The prevalence of latent/chronic infection in liver transplant candidates in Taleghani Hospital of Tehran, Iran, from 2020 until 2021.","authors":"Amirhassan Rabbani,&nbsp;Hesameddin Eghlimi,&nbsp;Mina Khoshkbarforoushan,&nbsp;Mana Baziboroun","doi":"10.22037/ghfbb.v16i1.2664","DOIUrl":"https://doi.org/10.22037/ghfbb.v16i1.2664","url":null,"abstract":"<p><strong>Aim: </strong>The present study aimed to study the prevalence of various latent infections in pre-transplanted patients.</p><p><strong>Background: </strong>Due to chronic immunosuppressive therapy, patients receiving organ transplants are at risk for reactivation of various infections. Due to the complications in the course of diagnosing and treating the post-transplant infection, screening transplant recipients and donors is vital.</p><p><strong>Methods: </strong>This retrospective cohort study was performed between March 2020 and 2021. A total of 193 patients receiving a liver transplant in Taleghani Hospital, Tehran, Iran were enrolled.</p><p><strong>Results: </strong>One-hundred and three (53.4%) patients were men, with an average age of 48.4 ± 13.3 years. Among viruses, 177 (91.7%) patients had a positive IgG titer for CMV. Anti-EBV IgG was positive in 169 (87.6%) patients. One-hundred and seventy-five (90.7%) patients had a positive IgG titer for the VZV. One-hundred and sixty-six (86.0%) cases had positive IgG anti-HSV antibodies. According to our findings, none of the patients were infected with HIV, but 9 (4.7%) cases and 141 (73.1%) had positive anti-HCV and anti-HAV IgG antibodies, respectively. HBV surface (HBs) antigen was also reported positive in 17 (8.8%) patients, while the HBs antibody was positive in 29 (15.0%) patients.</p><p><strong>Conclusion: </strong>In our study, most of the patients had positive serology for latent viral infections such as CMV, EBV, VZV, and HSV, but the prevalence of latent tuberculosis and viral hepatitis was low among transplant candidates.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 1","pages":"478-485"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4f/c2/GHFBB-16-478.PMC10105496.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9380018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The SW480 cell line, overexpressing PIWIL2 gene, maintains the expression of stemness and proliferation genes in the mice xenografts. 过表达PIWIL2基因的SW480细胞系在小鼠异种移植物中保持了干细胞和增殖基因的表达。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.22037/ghfbb.v16i1.2661
Roya Kishani Farahani, Ehsan Nazemalhosseini Mojarad, Hamid Reza Soleimanpour-Lichaei

Aim: This study aims to confirm previous fundamental in vitro findings about the PIWIL2 gene by investigating the effects of its overexpression on cell cycle, proliferation, apoptosis, and stem cell expression markers in colorectal cancer cells (CRC cells) at in vivo level.

Background: PIWIL2 has a critical role in maintaining cellular stemness and proliferation. PIWIL2 is an oncogene whose expression in CRC is associated with the occurrence, metastasis, and poor prognosis.

Methods: SW480 cells harboring expression vectors with/without PIWIL2 were cultured and inoculated in BALB/c nude mice. Tumor formation and growth were monitored every 3 days. On the 28th day after inoculation, the tumors were harvested for their total RNA extraction, and the expression profiling of the candidate genes was performed by Real-time PCR.

Results: Our results for the expression profiling of the xenografted tumors showed a significant increase in the expression of cancer stem cell markers, including CD24, CD133, and pluripotency marker SOX2 in the PIWIL2 over-expressing xenografts, compared to the control cell line. Moreover, PIWIL2 dramatically promoted the anti-apoptotic pathway by inducing STAT3 and BCL2-L1 genes in the PIWIL2 over-expressing xenografts, along with the up-regulation of Cyclin D1 and Ki-67 genes.

Conclusion: This research supports our prior in vitro findings, highlighting the critical role that PIWIL2 plays in the development of CRC and its substantial promise as a leading candidate for CRC-targeted therapy.

目的:本研究旨在通过在体内水平上研究PIWIL2基因过表达对结直肠癌细胞(CRC细胞)细胞周期、增殖、凋亡和干细胞表达标志物的影响,证实先前关于PIWIL2基因的基本体外研究结果。背景:PIWIL2在维持细胞干性和增殖中起关键作用。PIWIL2是一个癌基因,其在CRC中的表达与CRC的发生、转移和不良预后相关。方法:将携带PIWIL2或不携带PIWIL2表达载体的SW480细胞培养并接种BALB/c裸鼠。每3 d监测肿瘤形成和生长情况。接种后第28天收获肿瘤,提取总RNA, Real-time PCR检测候选基因的表达谱。结果:我们对异种移植肿瘤的表达谱分析结果显示,与对照细胞系相比,PIWIL2过表达的异种移植物中癌症干细胞标志物(包括CD24、CD133和多能性标志物SOX2)的表达显著增加。此外,PIWIL2通过在PIWIL2过表达的异种移植物中诱导STAT3和BCL2-L1基因,以及Cyclin D1和Ki-67基因的上调,显著促进了抗凋亡途径。结论:这项研究支持了我们之前的体外研究结果,强调了PIWIL2在CRC发展中的关键作用,以及它作为CRC靶向治疗的主要候选药物的巨大前景。
{"title":"The SW480 cell line, overexpressing PIWIL2 gene, maintains the expression of stemness and proliferation genes in the mice xenografts.","authors":"Roya Kishani Farahani,&nbsp;Ehsan Nazemalhosseini Mojarad,&nbsp;Hamid Reza Soleimanpour-Lichaei","doi":"10.22037/ghfbb.v16i1.2661","DOIUrl":"https://doi.org/10.22037/ghfbb.v16i1.2661","url":null,"abstract":"<p><strong>Aim: </strong>This study aims to confirm previous fundamental in vitro findings about the PIWIL2 gene by investigating the effects of its overexpression on cell cycle, proliferation, apoptosis, and stem cell expression markers in colorectal cancer cells (CRC cells) at in vivo level.</p><p><strong>Background: </strong>PIWIL2 has a critical role in maintaining cellular stemness and proliferation. PIWIL2 is an oncogene whose expression in CRC is associated with the occurrence, metastasis, and poor prognosis.</p><p><strong>Methods: </strong>SW480 cells harboring expression vectors with/without PIWIL2 were cultured and inoculated in BALB/c nude mice. Tumor formation and growth were monitored every 3 days. On the 28th day after inoculation, the tumors were harvested for their total RNA extraction, and the expression profiling of the candidate genes was performed by Real-time PCR.</p><p><strong>Results: </strong>Our results for the expression profiling of the xenografted tumors showed a significant increase in the expression of cancer stem cell markers, including CD24, CD133, and pluripotency marker SOX2 in the PIWIL2 over-expressing xenografts, compared to the control cell line. Moreover, PIWIL2 dramatically promoted the anti-apoptotic pathway by inducing STAT3 and BCL2-L1 genes in the PIWIL2 over-expressing xenografts, along with the up-regulation of Cyclin D1 and Ki-67 genes.</p><p><strong>Conclusion: </strong>This research supports our prior in vitro findings, highlighting the critical role that PIWIL2 plays in the development of CRC and its substantial promise as a leading candidate for CRC-targeted therapy.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 1","pages":"492-498"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/aa/14/GHFBB-16-492.PMC10105508.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9679455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and evaluation of a semi-nested PCR technique for amplification and determination of different surface gene variation patterns in patients with chronic HBV infection: development of an amplification method for HBV S gene. 用于慢性HBV感染患者不同表面基因变异模式扩增和测定的半巢式PCR技术的开发和评价:HBV S基因扩增方法的开发。
Q3 Medicine Pub Date : 2023-01-01
Fedra Mokhtari, Hami Kaboosi, Seyed Reza Mohebbi, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali

Aim: Development of an amplification method for further investigation of HBV S gene variation patterns.

Background: Pre-S/S variants in patients with chronic HBV infection may contribute to the progression of liver damage and Hepatocellular carcinoma (HCC).

Methods: This study was performed on ten patients with chronic HBV infection. Viral DNA was extracted from patient's plasma, primer design was performed, and a semi-nested PCR method was set up to amplify the pre-S/S region of HBV genome. Subsequently, sequencing was performed to analyze the variants of this region.

Results: In the current study, the semi-nested PCR method was successfully set up, and types of variation in the studied samples were investigated.

Conclusion: Pre-S/S variants should be routinely determined in HBV carriers to help identify individuals who may be at a high risk of less favorable liver disease progression. This study showed that the technique could accurately amplify the pre-S/S region, and the product can be successfully used for variation detection by direct sequencing.

目的:建立一种进一步研究HBV S基因变异模式的扩增方法。背景:慢性HBV感染患者的Pre-S/S变异可能促进肝损伤和肝细胞癌(HCC)的进展。方法:对10例慢性HBV感染患者进行研究。从患者血浆中提取病毒DNA,进行引物设计,建立半巢式PCR扩增HBV基因组前S/S区方法。随后,对该区域的变异进行测序分析。结果:本研究成功建立了半巢式PCR方法,并对所研究样品的变异类型进行了研究。结论:应在HBV携带者中常规检测Pre-S/S变异,以帮助识别可能处于较不利肝病进展高风险的个体。本研究表明,该技术能够准确扩增前S/S区,产品可成功用于直接测序的变异检测。
{"title":"Development and evaluation of a semi-nested PCR technique for amplification and determination of different surface gene variation patterns in patients with chronic HBV infection: development of an amplification method for HBV S gene.","authors":"Fedra Mokhtari,&nbsp;Hami Kaboosi,&nbsp;Seyed Reza Mohebbi,&nbsp;Hamid Asadzadeh Aghdaei,&nbsp;Mohammad Reza Zali","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim: </strong>Development of an amplification method for further investigation of HBV S gene variation patterns.</p><p><strong>Background: </strong>Pre-S/S variants in patients with chronic HBV infection may contribute to the progression of liver damage and Hepatocellular carcinoma (HCC).</p><p><strong>Methods: </strong>This study was performed on ten patients with chronic HBV infection. Viral DNA was extracted from patient's plasma, primer design was performed, and a semi-nested PCR method was set up to amplify the pre-S/S region of HBV genome. Subsequently, sequencing was performed to analyze the variants of this region.</p><p><strong>Results: </strong>In the current study, the semi-nested PCR method was successfully set up, and types of variation in the studied samples were investigated.</p><p><strong>Conclusion: </strong>Pre-S/S variants should be routinely determined in HBV carriers to help identify individuals who may be at a high risk of less favorable liver disease progression. This study showed that the technique could accurately amplify the pre-S/S region, and the product can be successfully used for variation detection by direct sequencing.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 1","pages":"520-523"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f5/ad/GHFBB-16-520.PMC10105500.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9679460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transient non-coeliac gluten sensitivity (NCGS) with markedly reduced villous height/crypt depth ratio. 瞬态非乳糜泻谷蛋白敏感性(NCGS),绒毛高度/隐窝深度比显著降低。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.22037/ghfbb.v16i2.2755
Charlotte Williams, Nicole Smith, Kamran Rostami

There is no confident evidence in the current literature to show or demonstrate that non-coeliac gluten sensitivity (NCGS) exclusively presents with mild or nearly normal duodenal mucosal abnormality. Gluten sensitive patients with negative serology and severe mucosal changes are labelled with the term seronegative coeliac disease (SNCS). There might be at least some overlap between NCGS and SNCD. Transient gluten sensitivity with severe mucosal changes without CD have been previously reported like in our case.

目前文献中没有可靠的证据表明或证明非乳糜泻麸质敏感性(NCGS)仅表现为轻度或接近正常的十二指肠黏膜异常。血清阴性和严重粘膜改变的麸质敏感患者被标记为血清阴性乳糜泻(SNCS)。NCGS和SNCD之间可能至少有一些重叠。短暂的麸质敏感伴严重的粘膜改变而不伴有乳糜泻以前也有报道,如本病例。
{"title":"Transient non-coeliac gluten sensitivity (NCGS) with markedly reduced villous height/crypt depth ratio.","authors":"Charlotte Williams,&nbsp;Nicole Smith,&nbsp;Kamran Rostami","doi":"10.22037/ghfbb.v16i2.2755","DOIUrl":"https://doi.org/10.22037/ghfbb.v16i2.2755","url":null,"abstract":"<p><p>There is no confident evidence in the current literature to show or demonstrate that non-coeliac gluten sensitivity (NCGS) exclusively presents with mild or nearly normal duodenal mucosal abnormality. Gluten sensitive patients with negative serology and severe mucosal changes are labelled with the term seronegative coeliac disease (SNCS). There might be at least some overlap between NCGS and SNCD. Transient gluten sensitivity with severe mucosal changes without CD have been previously reported like in our case.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 2","pages":"222-224"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b9/a3/GHFBB-16-222.PMC10404823.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10559740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
No-biopsy diagnostic approach to coeliac disease. 乳糜泻的无活检诊断方法。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.22037/ghfbb.v16i2.2706
Geoffrey Holmes

This brief review outlines contributions that Michael Marsh and others made to understanding the structure and function of the upper small bowel mucosa and the formation of abnormalities that occur in coeliac disease (CD). He introduced his classification of lesions 30 years ago that has been widely adopted. The development and use of serological tests to screen for and diagnose CD in children and adults without the need for a small bowel biopsy in a considerable proportion is also recognised and will gain traction.

这篇简短的综述概述了Michael Marsh和其他人在理解小肠上部粘膜的结构和功能以及乳糜泻(CD)中发生的异常形成方面的贡献。他在30年前提出的病变分类已被广泛采用。开发和使用血清学测试来筛查和诊断儿童和成人的乳糜泻,而不需要在相当大的比例上进行小肠活检,也得到了认可,并将获得推动。
{"title":"No-biopsy diagnostic approach to coeliac disease.","authors":"Geoffrey Holmes","doi":"10.22037/ghfbb.v16i2.2706","DOIUrl":"https://doi.org/10.22037/ghfbb.v16i2.2706","url":null,"abstract":"<p><p>This brief review outlines contributions that Michael Marsh and others made to understanding the structure and function of the upper small bowel mucosa and the formation of abnormalities that occur in coeliac disease (CD). He introduced his classification of lesions 30 years ago that has been widely adopted. The development and use of serological tests to screen for and diagnose CD in children and adults without the need for a small bowel biopsy in a considerable proportion is also recognised and will gain traction.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 2","pages":"112-117"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cf/82/GHFBB-16-112.PMC10404819.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10559743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of acupressure on intestinal function in patients with coronary artery bypass graft surgery: a randomized clinical trial. 穴位按压对冠状动脉搭桥术患者肠道功能的影响:一项随机临床试验。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.22037/ghfbb.v16i2.2720
Fatemeh Khan-Mohammadi, Hedayat Jafari, Masoumeh Bagheri-Nesami, Mahmood Moosazadeh, Mahsa Kamali, Nadali Esmaeili-Ahangarkelai, Kamran Quds

Aim: This study aimed to determine the effects of acupressure on the intestinal function of patients undergoing Coronary Artery Bypass Graft (CABG) surgery.

Background: Studies indicated that cardiovascular patients are prone to constipation. Acupressure is one of the therapeutic and palliative approaches that can be used by doctors, nurses, and even patients themselves.

Methods: The present three-group randomized clinical trial study was conducted on 90 patients undergoing CABG surgery. In the intervention group, 48 hours after surgery the patients received acupressure points LI4 and ST25 twice a day (10 am and 6 pm) for three sequential days. In the sham group, the patients received acupressure at a 1.5 cm distance from the LI4-ST25 points, and the patients in the control group received only the usual care. This research used a demographic and medical information questionnaire, Rome IV scale, Bristol stool scale, symptom registration checklist, and daily excretion assessment checklist. The intestinal function indices were completed 24 hours after surgery (before intervention), 48, 72, 96, and 120 hours after surgery.

Results: All three intervention, sham, and control groups were without defecation in 24 hours (before intervention) and 48 hours after surgery. There was a significant difference between the three intervention, sham, and control groups in the number of stools after 72 hours, 96 hours, and 120 hours after the intervention (p<0.001). Also, a significant difference was observed among the three groups in terms of stool consistency 96 hours after the start of the intervention (p=0.032) and 120 hours after the start of the intervention (p<0.001).

Conclusion: The results showed that patients had a significant improvement in the number of bowel movements and stool consistency in the intervention group. In acute conditions, acupressure on LI4-ST25 points can positively affect intestinal function when patients are hospitalized in the intensive care unit.

目的:本研究旨在确定穴位按压对冠状动脉搭桥术(CABG)患者肠道功能的影响。背景:研究表明,心血管疾病患者容易出现便秘。穴位按压是一种治疗和姑息的方法,医生、护士甚至病人自己都可以使用。方法:对90例冠状动脉旁路移植术患者进行三组随机临床试验研究。在干预组中,手术后48小时,患者接受穴位LI4和ST25,每天两次(上午10点和下午6点),连续三天。在假手术组中,患者在距离LI4-ST25点1.5cm处接受穴位按压,而对照组中的患者仅接受常规护理。本研究使用了人口统计学和医学信息问卷、罗马IV量表、布里斯托尔粪便量表、症状登记表和每日排泄评估表。术后24小时(干预前)、术后48、72、96和120小时完成肠功能指标。结果:干预组、假手术组和对照组在干预前24小时和手术后48小时均未排便。三个干预组、假手术组和对照组在72小时、96小时后的排便次数有显著差异,结论:干预组患者排便次数和大便稠度均有明显改善,在急性情况下,在重症监护室住院时,针刺LI4-ST25穴可对肠功能产生积极影响。
{"title":"Effects of acupressure on intestinal function in patients with coronary artery bypass graft surgery: a randomized clinical trial.","authors":"Fatemeh Khan-Mohammadi,&nbsp;Hedayat Jafari,&nbsp;Masoumeh Bagheri-Nesami,&nbsp;Mahmood Moosazadeh,&nbsp;Mahsa Kamali,&nbsp;Nadali Esmaeili-Ahangarkelai,&nbsp;Kamran Quds","doi":"10.22037/ghfbb.v16i2.2720","DOIUrl":"https://doi.org/10.22037/ghfbb.v16i2.2720","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to determine the effects of acupressure on the intestinal function of patients undergoing Coronary Artery Bypass Graft (CABG) surgery.</p><p><strong>Background: </strong>Studies indicated that cardiovascular patients are prone to constipation. Acupressure is one of the therapeutic and palliative approaches that can be used by doctors, nurses, and even patients themselves.</p><p><strong>Methods: </strong>The present three-group randomized clinical trial study was conducted on 90 patients undergoing CABG surgery. In the intervention group, 48 hours after surgery the patients received acupressure points LI4 and ST25 twice a day (10 am and 6 pm) for three sequential days. In the sham group, the patients received acupressure at a 1.5 cm distance from the LI4-ST25 points, and the patients in the control group received only the usual care. This research used a demographic and medical information questionnaire, Rome IV scale, Bristol stool scale, symptom registration checklist, and daily excretion assessment checklist. The intestinal function indices were completed 24 hours after surgery (before intervention), 48, 72, 96, and 120 hours after surgery.</p><p><strong>Results: </strong>All three intervention, sham, and control groups were without defecation in 24 hours (before intervention) and 48 hours after surgery. There was a significant difference between the three intervention, sham, and control groups in the number of stools after 72 hours, 96 hours, and 120 hours after the intervention (p<0.001). Also, a significant difference was observed among the three groups in terms of stool consistency 96 hours after the start of the intervention (p=0.032) and 120 hours after the start of the intervention (p<0.001).</p><p><strong>Conclusion: </strong>The results showed that patients had a significant improvement in the number of bowel movements and stool consistency in the intervention group. In acute conditions, acupressure on LI4-ST25 points can positively affect intestinal function when patients are hospitalized in the intensive care unit.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 3","pages":"282-291"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bf/c2/GHFBB-16-282.PMC10520391.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41112061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychometric properties of Persian version of irritable bowel syndrome- behavioral responses questionnaire (IBS-BRQ). 波斯版肠易激综合征的心理测量特性-行为反应问卷(IBS-BRQ)。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.22037/ghfbb.v16i2.2440
Amrollah Ebrahimi, Mohammad Forghani, Masoudeh Bababkhanian, Mehdi Ebrahimi, Peyman Adibi Sedeh

Aim: This study aimed to determine the psychometric properties of Persian version of Irritable Bowel Syndrome-Behavioral Responses Questionnaire (IBS-BRQ).

Background: In addition to somatic symptoms and complaints, patients with irritable bowel syndrome have specific dysfunctional behaviors that lead to disease persistence and functional disturbance.

Methods: Participants included 170 patients with irritable bowel syndrome, who were diagnosed based on ROM-IV criteria and selected from patients referring to the Gastrointestinal Disorders Clinic, as well as 100 persons from the general population in Isfahan in 2020. Both groups completed the 26-item Irritable Bowel Syndrome-Behavioral Responses Questionnaire (IBS-BRQ). Also, questionnaires including the Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS), Irritable Bowel Syndrome-Quality of Life IBS-QOL, Illness Perception Questionnaire (IPQ-R), Irritable Bowel Syndrome-Patient Satisfaction (IBS-SAT), Hope Scale, Interpersonal Forgiveness Inventory (IFI), and Dysfunctional Attitude Scale- 26-item (DAS-26) were completed to determine the validity of IBS-BRQ. Tests of internal consistency, principal components analyses (PCAs), differentiation analysis, and correlation were used to determine its reliability, along with criterion and construct validity.

Results: IBS-BRQ was valid and reliable in both groups with a high degree of internal consistency. Cronbach's alpha was obtained in the sample of patients with IBS and the total sample of participants 0.87 and 0.95 respectively. This scale differentiated significantly between IBS patients and non-patients (p<.001). The criterion validity was high as evidenced by a high correlation with DAS-26 (r=0.53, p<0.001), IBS-QOL (r=0.76, p<0.001), IBS-SSS (r=0.44, p<0.001), IPQ-R (r=0.56, p<0.001), and reverse correlation with IFI (r=-0.031, p<0.001), IBS-SAT (r=-0.23, p<0.001), and HOPE (r=-0.49, p<0.001).

Conclusion: The Persian version of the IBS-BRQ proved to be a well-defined behavioral response measure in IBS patients with high validity and reliability, making it a suitable measure to be used in future IBS clinical research in Iran.

目的:本研究旨在确定波斯版肠易激综合征行为反应问卷(IBS-BRQ)的心理测量特性。方法:参与者包括170名肠易激综合征患者,他们是根据ROM-IV标准诊断的,选自胃肠道疾病诊所的患者,以及2020年伊斯法罕普通人群中的100人。两组均完成了26项的肠易激综合征行为反应问卷(IBS-BRQ)。此外,问卷包括肠易激综合征症状严重程度量表(IBS-SSS)、肠易激综合症生活质量IBS-QOL、疾病感知问卷(IPQ-R)、肠难激综合征患者满意度(IBS-SAT)、希望量表、人际宽恕量表(IFI),完成功能障碍态度量表-26项(DAS-26),以确定IBS-BRQ的有效性。内部一致性检验、主成分分析(PCA)、差异分析和相关性检验用于确定其可靠性,以及标准和结构有效性。结果:IBS-BRQ在两组中均有效可靠,具有高度的内部一致性。在IBS患者样本和参与者总样本中分别获得0.87和0.95的克朗巴赫α。该量表在IBS患者和非患者之间有显著差异(P结论:波斯版IBS-BRQ被证明是IBS患者的一种明确的行为反应测量方法,具有较高的有效性和可靠性,是伊朗未来IBS临床研究中使用的一种合适的测量方法。
{"title":"Psychometric properties of Persian version of irritable bowel syndrome- behavioral responses questionnaire (IBS-BRQ).","authors":"Amrollah Ebrahimi,&nbsp;Mohammad Forghani,&nbsp;Masoudeh Bababkhanian,&nbsp;Mehdi Ebrahimi,&nbsp;Peyman Adibi Sedeh","doi":"10.22037/ghfbb.v16i2.2440","DOIUrl":"https://doi.org/10.22037/ghfbb.v16i2.2440","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to determine the psychometric properties of Persian version of Irritable Bowel Syndrome-Behavioral Responses Questionnaire (IBS-BRQ).</p><p><strong>Background: </strong>In addition to somatic symptoms and complaints, patients with irritable bowel syndrome have specific dysfunctional behaviors that lead to disease persistence and functional disturbance.</p><p><strong>Methods: </strong>Participants included 170 patients with irritable bowel syndrome, who were diagnosed based on ROM-IV criteria and selected from patients referring to the Gastrointestinal Disorders Clinic, as well as 100 persons from the general population in Isfahan in 2020. Both groups completed the 26-item Irritable Bowel Syndrome-Behavioral Responses Questionnaire (IBS-BRQ). Also, questionnaires including the Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS), Irritable Bowel Syndrome-Quality of Life IBS-QOL, Illness Perception Questionnaire (IPQ-R), Irritable Bowel Syndrome-Patient Satisfaction (IBS-SAT), Hope Scale, Interpersonal Forgiveness Inventory (IFI), and Dysfunctional Attitude Scale- 26-item (DAS-26) were completed to determine the validity of IBS-BRQ. Tests of internal consistency, principal components analyses (PCAs), differentiation analysis, and correlation were used to determine its reliability, along with criterion and construct validity.</p><p><strong>Results: </strong>IBS-BRQ was valid and reliable in both groups with a high degree of internal consistency. Cronbach's alpha was obtained in the sample of patients with IBS and the total sample of participants 0.87 and 0.95 respectively. This scale differentiated significantly between IBS patients and non-patients (p<.001). The criterion validity was high as evidenced by a high correlation with DAS-26 (r=0.53, p<0.001), IBS-QOL (r=0.76, p<0.001), IBS-SSS (r=0.44, p<0.001), IPQ-R (r=0.56, p<0.001), and reverse correlation with IFI (r=-0.031, p<0.001), IBS-SAT (r=-0.23, p<0.001), and HOPE (r=-0.49, p<0.001).</p><p><strong>Conclusion: </strong>The Persian version of the IBS-BRQ proved to be a well-defined behavioral response measure in IBS patients with high validity and reliability, making it a suitable measure to be used in future IBS clinical research in Iran.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 3","pages":"326-335"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7e/bf/GHFBB-16-326.PMC10520395.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41117107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Autologous platelet-rich-plasma injection and platelet-rich fibrin glue interposition for treatment of anal fistula resistant to surgery. 自体富含血小板的血浆注射和富含血小板的纤维蛋白胶介入治疗对手术有抵抗力的肛瘘。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.22037/ghfbb.v16i2.2719
Abbas Abdollahi, Elaheh Emadi, Daryoush Hamidi Alamdari

Aim: The current study purposed to evaluate the autologous platelet-rich plasma (PRP), and platelet-rich fibrin glue (PRFG) effect on the treatment of complex, and recalcitrant anal fistula (AF) which was not cured by several surgeries.

Background: AF has remained one of difficult challenges for centuries. Surgery is the common treatment method for it, but the risk of fecal incontinence and recurrence is still a distressing complication for patients and surgeons. New procedures were published in the scientific literature, each with advantages and disadvantages. According to reports, an effective therapy option is the autologous fibrin glue that is rich in platelets.

Methods: Autologous PRP and PRFG were prepared from 10 patients' own blood. The surgeon curetted the tract of anal fistula for the deepithelialisation till hemorrhage occurred; PRP was injected around the fistula into the tissue, and PRFG was interpositioned in the tract. Age, number of previous surgeries, complications, number of PRP and PRFG administrations, and duration of halting the discharge were among the information gathered. Patients were followed up between 10 months to 84 months after treatment.

Results: No complications were observed during and after the injection. During the period of follow-up, AF leakage was stopped for 6 patients, but not for 4 patients.

Conclusion: Since autologous PRP injection, and PRFG interposition is a safe, effective, and minimally invasive procedure for resistant AF to surgeries; it can be used, along with surgery to increase the healing rate of complex anal fistula.

目的:本研究旨在评估自体富血小板血浆(PRP)和富血小板纤维蛋白胶(PRFG)治疗多次手术均未治愈的复杂顽固性肛瘘(AF)的效果。背景:几个世纪以来,AF一直是一项艰巨的挑战。手术是常见的治疗方法,但大便失禁和复发的风险仍然是患者和外科医生的一个令人痛苦的并发症。科学文献中发表了新的程序,每种程序都有优点和缺点。据报道,一种有效的治疗选择是富含血小板的自体纤维蛋白胶。方法:从10例患者自身血中制备自体PRP和PRFG。外科医生刮除肛瘘管进行深度脱管,直至出血;在瘘管周围将PRP注射到组织中,并将PRFG插入尿道中。收集的信息包括年龄、既往手术次数、并发症、PRP和PRFG给药次数以及停止出院的持续时间。患者在治疗后10个月至84个月进行随访。结果:注射期间和注射后均未观察到并发症。在随访期间,6名患者停止了房颤渗漏,但4名患者未停止。结论:自体PRP注射加PRFG介入治疗难治性房颤是一种安全、有效、微创的治疗方法;它可以与手术一起使用,以提高复杂肛瘘的治愈率。
{"title":"Autologous platelet-rich-plasma injection and platelet-rich fibrin glue interposition for treatment of anal fistula resistant to surgery.","authors":"Abbas Abdollahi,&nbsp;Elaheh Emadi,&nbsp;Daryoush Hamidi Alamdari","doi":"10.22037/ghfbb.v16i2.2719","DOIUrl":"https://doi.org/10.22037/ghfbb.v16i2.2719","url":null,"abstract":"<p><strong>Aim: </strong>The current study purposed to evaluate the autologous platelet-rich plasma (PRP), and platelet-rich fibrin glue (PRFG) effect on the treatment of complex, and recalcitrant anal fistula (AF) which was not cured by several surgeries.</p><p><strong>Background: </strong>AF has remained one of difficult challenges for centuries. Surgery is the common treatment method for it, but the risk of fecal incontinence and recurrence is still a distressing complication for patients and surgeons. New procedures were published in the scientific literature, each with advantages and disadvantages. According to reports, an effective therapy option is the autologous fibrin glue that is rich in platelets.</p><p><strong>Methods: </strong>Autologous PRP and PRFG were prepared from 10 patients' own blood. The surgeon curetted the tract of anal fistula for the deepithelialisation till hemorrhage occurred; PRP was injected around the fistula into the tissue, and PRFG was interpositioned in the tract. Age, number of previous surgeries, complications, number of PRP and PRFG administrations, and duration of halting the discharge were among the information gathered. Patients were followed up between 10 months to 84 months after treatment.</p><p><strong>Results: </strong>No complications were observed during and after the injection. During the period of follow-up, AF leakage was stopped for 6 patients, but not for 4 patients.</p><p><strong>Conclusion: </strong>Since autologous PRP injection, and PRFG interposition is a safe, effective, and minimally invasive procedure for resistant AF to surgeries; it can be used, along with surgery to increase the healing rate of complex anal fistula.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 3","pages":"292-296"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9f/d5/GHFBB-16-292.PMC10520388.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41117170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the influence of environmental risk factors on inflammatory bowel diseases: a case-control study. 评估环境危险因素对炎症性肠病的影响:一项病例对照研究。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.22037/ghfbb.v16i2.2576
Rahil Riahi, Saeed Abdi, Sara Ashtari, Habib Malekpour

Aim: This study aimed to examine the environmental factors associated in Iranian patients with inflammatory bowel disease (IBD).

Background: The role of environmental factors in the development of IBD remains uncertain.

Methods: In this case-control study, the patients with IBD referred to the Taleghani Hospital, Tehran, Iran, were recruited from 2017 to 2019. Controls were matched by sex. Data were collected using the designed questionnaire and also valid questionnaire such Pittsburgh Sleep Quality Index (PSQI) and Hospital Anxiety and Depression Scale (HADS) for sleep quality and anxiety/depression, respectively. Conditional logistic regression models were used to estimate adjusted odds ratios (ORs).

Results: The study population included 200 individuals: 100 (50%) IBD patients and 100 (50%) controls. Age under 50, marital status, sleep difficulties, vitamin D insufficiency, anxiety/depression, dietary fiber deficit, post-menopausal hormone treatment, oral contraceptives, and antibiotics were all prognostic factors for IBD on the univariate analysis (P< 0.005). In multivariate analysis, the risk of IBD was significantly increased with 50 years (OR: 6.699, 95%CI: 3.271-8.662, P=0.017), abnormal sleep status (OR: 6.383, 95%CI: 3.389-7.19, P=0.001), and using oral contraceptive (OR: 7.426, 95%CI: 5.327-9.865, P=0.001). However, the risk of IBD was significantly decreased with older age (OR: 0.795, 95%CI: 0.697-0.907, P=0.001) and married status (OR: 0.008, 95%CI: 0.001-0.438, P=0.018).

Conclusion: Data suggest that the environmental factors play a significant role in the etiology of IBD and probably on the disease course. While the evidence for some factors is strong, many factors require further supportive data.

目的:本研究旨在检测伊朗炎症性肠病(IBD)患者的相关环境因素。背景:环境因素在IBD发展中的作用尚不确定。方法:在这项病例对照研究中,2017年至2019年,伊朗德黑兰Taleghani医院的IBD患者被招募。对照组按性别匹配。使用设计的问卷和有效的问卷,如匹兹堡睡眠质量指数(PSQI)和医院焦虑抑郁量表(HADS),分别收集睡眠质量和焦虑/抑郁的数据。结果:研究人群包括200人:100名IBD患者(50%)和100名对照组(50%)。单因素分析显示,50岁以下的年龄、婚姻状况、睡眠困难、维生素D缺乏、焦虑/抑郁、膳食纤维缺乏、绝经后激素治疗、口服避孕药和抗生素都是IBD的预后因素(P<0.005)。多因素分析表明,IBD的风险随着50年的增长而显著增加(OR:6.699,95%CI:3.271-8.662,P=0.017),睡眠状态异常(OR:6.383,95%CI:3.389-7.19,P=0.001)和使用口服避孕药(OR:7.426,95%CI:5.327-9.865,P=0.001,随着年龄的增长(OR:0.795,95%CI:0.97-0.907,P=0.001)和婚姻状况(OR:0.08,95%CI:0.001-0.438,P=0.018),IBD的风险显著降低。虽然某些因素的证据很充分,但许多因素需要进一步的支持性数据。
{"title":"Evaluating the influence of environmental risk factors on inflammatory bowel diseases: a case-control study.","authors":"Rahil Riahi,&nbsp;Saeed Abdi,&nbsp;Sara Ashtari,&nbsp;Habib Malekpour","doi":"10.22037/ghfbb.v16i2.2576","DOIUrl":"https://doi.org/10.22037/ghfbb.v16i2.2576","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to examine the environmental factors associated in Iranian patients with inflammatory bowel disease (IBD).</p><p><strong>Background: </strong>The role of environmental factors in the development of IBD remains uncertain.</p><p><strong>Methods: </strong>In this case-control study, the patients with IBD referred to the Taleghani Hospital, Tehran, Iran, were recruited from 2017 to 2019. Controls were matched by sex. Data were collected using the designed questionnaire and also valid questionnaire such Pittsburgh Sleep Quality Index (PSQI) and Hospital Anxiety and Depression Scale (HADS) for sleep quality and anxiety/depression, respectively. Conditional logistic regression models were used to estimate adjusted odds ratios (ORs).</p><p><strong>Results: </strong>The study population included 200 individuals: 100 (50%) IBD patients and 100 (50%) controls. Age under 50, marital status, sleep difficulties, vitamin D insufficiency, anxiety/depression, dietary fiber deficit, post-menopausal hormone treatment, oral contraceptives, and antibiotics were all prognostic factors for IBD on the univariate analysis (P< 0.005). In multivariate analysis, the risk of IBD was significantly increased with 50 years (OR: 6.699, 95%CI: 3.271-8.662, P=0.017), abnormal sleep status (OR: 6.383, 95%CI: 3.389-7.19, P=0.001), and using oral contraceptive (OR: 7.426, 95%CI: 5.327-9.865, P=0.001). However, the risk of IBD was significantly decreased with older age (OR: 0.795, 95%CI: 0.697-0.907, P=0.001) and married status (OR: 0.008, 95%CI: 0.001-0.438, P=0.018).</p><p><strong>Conclusion: </strong>Data suggest that the environmental factors play a significant role in the etiology of IBD and probably on the disease course. While the evidence for some factors is strong, many factors require further supportive data.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 3","pages":"307-318"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d7/b0/GHFBB-16-307.PMC10520386.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41133608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survival of gastric cancer patients in Iran: a systematic review and meta-analysis. 伊朗癌症患者生存率的系统回顾和荟萃分析。
Q3 Medicine Pub Date : 2023-01-01 DOI: 10.22037/ghfbb.v16i2.2674
Fargol Farahmandi, Mohammad-Mahdi Salarabedi, Parynaz Parhizgar, Swetha Variyath, Nabeel Al-Yateem, Syed Azizur Rahman, Amina Al-Marzouqi, Saeed Hashemi Nazari, Alireza Mosavi Jarrahi

Aim: This study aimed to estimate the survival rates among Iranian gastric cancer patients and to evaluate if the survival has improved during the last three decades.

Background: Gastric cancer is one of the most common cancers in Iran with high mortality.

Methods: A systematic review and meta-analysis of all published studies addressing gastric cancer survival in Iran was performed. International databases of Scopus, Web of Science, PubMed, and Iranian databases were included in the study. The study included databases from their inception till February 2022. Due to the inherent heterogeneity, we used a random effect model to pool the survivals in three categories of one, three, and five-year survivals.

Results: Thirty-three studies with total cases of 17,207 were included in the study. The overall (pooled) one, three, and five-year survivals were estimated as 58.9% (95% CI: 0.52, 0.66), 29.9% (95% CI: 0.25, 0.35), and 18.2% (95% CI: 0.15, 0.23), respectively. Results of subgroup analysis for the calendar years of study showed that the one, three, and five-year survival rates increased during the last three decades but the results were not statistically significant. There was the disparity in survival based on geographic distribution.

Conclusion: The results of our study which has pooled many studies for a long period of time clearly indicate that the survival rates of gastric cancer patients have improved. As the improvement of survival may be due to many factors, more studies is needed to understand the dynamic behind this improvement.

目的:本研究旨在评估伊朗癌症患者的生存率,并评估在过去三十年中生存率是否有所改善。背景:癌症是伊朗最常见的癌症之一,死亡率高。方法:对伊朗所有已发表的关于癌症生存率的研究进行系统回顾和荟萃分析。Scopus、Web of Science、PubMed和伊朗数据库的国际数据库也包括在该研究中。这项研究包括从成立到2022年2月的数据库。由于固有的异质性,我们使用随机效应模型将生存率分为一年、三年和五年三类。结果:本研究共纳入33项研究,总病例数为17207例。总的(合并的)一年、三年和五年生存率估计分别为58.9%(95%CI:0.52、0.66)、29.9%(95%CI=0.25、0.35)和18.2%(95%CI:0.15、0.23)。研究日历年的亚组分析结果显示,在过去三十年中,一年、三年和五年的生存率有所上升,但结果没有统计学意义。存在着基于地理分布的生存差异。结论:本研究长期收集了大量研究结果,清楚地表明癌症患者的生存率有所提高。由于生存率的提高可能是由许多因素造成的,因此需要更多的研究来了解这种提高背后的动态。
{"title":"Survival of gastric cancer patients in Iran: a systematic review and meta-analysis.","authors":"Fargol Farahmandi,&nbsp;Mohammad-Mahdi Salarabedi,&nbsp;Parynaz Parhizgar,&nbsp;Swetha Variyath,&nbsp;Nabeel Al-Yateem,&nbsp;Syed Azizur Rahman,&nbsp;Amina Al-Marzouqi,&nbsp;Saeed Hashemi Nazari,&nbsp;Alireza Mosavi Jarrahi","doi":"10.22037/ghfbb.v16i2.2674","DOIUrl":"https://doi.org/10.22037/ghfbb.v16i2.2674","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to estimate the survival rates among Iranian gastric cancer patients and to evaluate if the survival has improved during the last three decades.</p><p><strong>Background: </strong>Gastric cancer is one of the most common cancers in Iran with high mortality.</p><p><strong>Methods: </strong>A systematic review and meta-analysis of all published studies addressing gastric cancer survival in Iran was performed. International databases of Scopus, Web of Science, PubMed, and Iranian databases were included in the study. The study included databases from their inception till February 2022. Due to the inherent heterogeneity, we used a random effect model to pool the survivals in three categories of one, three, and five-year survivals.</p><p><strong>Results: </strong>Thirty-three studies with total cases of 17,207 were included in the study. The overall (pooled) one, three, and five-year survivals were estimated as 58.9% (95% CI: 0.52, 0.66), 29.9% (95% CI: 0.25, 0.35), and 18.2% (95% CI: 0.15, 0.23), respectively. Results of subgroup analysis for the calendar years of study showed that the one, three, and five-year survival rates increased during the last three decades but the results were not statistically significant. There was the disparity in survival based on geographic distribution.</p><p><strong>Conclusion: </strong>The results of our study which has pooled many studies for a long period of time clearly indicate that the survival rates of gastric cancer patients have improved. As the improvement of survival may be due to many factors, more studies is needed to understand the dynamic behind this improvement.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 3","pages":"245-258"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/94/7b/GHFBB-16-245.PMC10520396.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41148856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gastroenterology and Hepatology From Bed to Bench
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1